Meiji Yasuda Asset Management Co Ltd. Sells 703 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Meiji Yasuda Asset Management Co Ltd. reduced its holdings in Intuitive Surgical, Inc. by 3.7% during Q1, owning 18,429 shares valued at $9.1 million after selling 703 shares.
• A number of institutional investors significantly increased their positions in Intuitive Surgical, with Chilton Capital Management boosting its holdings by 614.3%.
• Analysts have mixed views on Intuitive Surgical, with 13 giving a Buy rating while others, including Zacks Research, downgraded the stock to a Hold rating.

Meiji Yasuda Asset Management Co Ltd. reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 18,429 shares of the medical equipment provider's stock after selling 703 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.'s holdings in Intuitive Surgical were worth $9,127,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. AlphaCore Capital LLC grew its holdings in Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after acquiring an additional 18 shares during the period. Second Line Capital LLC grew its holdings in Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after acquiring an additional 19 shares during the period. Crown Wealth Group LLC increased its stake in Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after purchasing an additional 20 shares in the last quarter. FSM Wealth Advisors LLC increased its stake in Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after purchasing an additional 20 shares in the last quarter. Finally, CFO4Life Group LLC increased its stake in Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock valued at $216,000 after purchasing an additional 20 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $6.17 on Friday, reaching $449.68. The company had a trading volume of 2,217,474 shares, compared to its average volume of 2,025,305. The firm has a market capitalization of $161.20 billion, a price-to-earnings ratio of 62.72, a price-to-earnings-growth ratio of 4.72 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company's fifty day moving average is $487.55 and its 200-day moving average is $509.57.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.78 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on ISRG shares. Piper Sandler reissued an "overweight" rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. UBS Group boosted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Citigroup reissued a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.